NAICS 325412: Pharmaceutical Preparation Manufacturing
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

ExioML sector: Chemicals nec
Region: US | Year: 2022
Sector value added: 183879.917188 M EUR | Employment: 2033.54236812 thousand persons
Sector GHG emissions: 125728834468.0 kg CO2 eq | Energy carrier net total: 3186425.50957 TJ | Carbon intensity: 0.6837551179635024

Company: Qsa Global Inc
QSA Global, Inc. has over 60 years of experience as the industry leader developing and manufacturing sealed radioactive sources for industrial gauging and analysis. Our industrial sources are designed for numerous gauging applications including density, level, coal, and cement analysis.